🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective observational study that will follow patients who und...
Status
Recruiting
Location
Zuckerberg San Francisco General Hospital and Trauma Center
Start Date
2017-12-17
Trial ID
NCT03774758
Treatments Being Tested
Pediatric soft tissue sarcoma is made up of different subtypes, some of whi...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2022-10-01
Trial ID
NCT05778955
Treatments Being Tested
Patient with histologically proven NSCLC in a metastatic stage, treatment n...
Status
Recruiting
Location
Hopital Ambroise Pare
Start Date
2021-05-22
Trial ID
NCT04790682
The goal of this observational study is to explore whether ctDNA-MRD dynami...
Status
Not Yet Recruiting
Location
Department of Thoracic Surgery, Second Xiangya Hospital of Central South University, China
Start Date
2023-04
Trial ID
NCT05822284
Treatments Being Tested
The second generation of high-throughput gene sequencing (NGS) is an import...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2017-10-21
Trial ID
NCT03465241
Treatments Being Tested
This is a prospective pilot study to assess dynamic changes of plasma cell-...
Status
Recruiting
Location
Ballad Health Cancer Care
Start Date
2025-02-11
Trial ID
NCT06849518
Treatments Being Tested
This study is a genetic analysis of aberrations in circulating tumor DNA (c...
Status
Unknown
Location
National Cancer Center Hospital
Start Date
2021-11-01
Trial ID
NCT05099978
Treatments Being Tested
In cooperation with the molecular tumor board of the University Hospital Tü...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-10
Trial ID
NCT05871593
Treatments Being Tested
For patients with breast cancer, it's important to find any remaining cance...
Status
Recruiting
Location
Birmingham Hematology Associates
Start Date
2025-10-27
Trial ID
NCT07211178
Treatments Being Tested
Osimertinib is an epidermal growth factor receptor tyrosine kinase inhibito...
Status
Unknown
Location
CHU d'ANGERS
Start Date
2019-04-09
Trial ID
NCT03865511
Treatments Being Tested